These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15640816)

  • 1. The importance of identifying a back-up donor for unrelated stem cell transplantation.
    van Walraven SM; Heemskerk MB; Lie JL; Barge RM; Cornelissen JJ; Egeler RM; Verdonck LF; Wulffraat N; Oudshoorn M
    Bone Marrow Transplant; 2005 Mar; 35(5):437-40. PubMed ID: 15640816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!
    Heemskerk MB; van Walraven SM; Cornelissen JJ; Barge RM; Bredius RG; Egeler RM; Tj Lie JL; Révész T; Sintnicolaas K; Wulffraat NM; Donker AE; Hoogerbrugge PM; van Rood JJ; Claas FH; Oudshoorn M
    Bone Marrow Transplant; 2005 Apr; 35(7):645-52. PubMed ID: 15723086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.
    Hurley CK; Raffoux C;
    Bone Marrow Transplant; 2004 Jul; 34(2):103-10. PubMed ID: 15170173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
    Shaw BE; Russell NH; Devereux S; Das-Gupta E; Mackinnon S; Madrigal JA; Pagliuca A; Mufti GJ; Byrne JL
    Haematologica; 2005 Nov; 90(11):1562-9. PubMed ID: 16266905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).
    Wiegand T; Raffoux C; Hurley CK; Kern M; Oudshoorn M; Raymond J; Cleaver S; Marry E; Muller C; ;
    Bone Marrow Transplant; 2004 Jul; 34(2):97-101. PubMed ID: 15170174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.
    Cairo MS; Rocha V; Gluckman E; Hale G; Wagner J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):44-53. PubMed ID: 18162220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
    Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
    Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national program for nondirected kidney donation from living unrelated donors: the Philippine experience.
    Manauis MN; Pilar KA; Lesaca R; de Belen Uriarte R; Danguilan R; Ona E
    Transplant Proc; 2008 Sep; 40(7):2100-3. PubMed ID: 18790164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
    Lang P; Mueller I; Greil J; Bader P; Schumm M; Pfeiffer M; Hoelle W; Klingebiel T; Heinzelmann F; Belka C; Schlegel PG; Kremens B; Woessmann W; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):33-9. PubMed ID: 17884640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor commitment and patient needs.
    Bakken R; van Walraven AM; Egeland T;
    Bone Marrow Transplant; 2004 Jan; 33(2):225-30. PubMed ID: 14628078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family donor care management: principles and recommendations.
    van Walraven SM; Nicoloso-de Faveri G; Axdorph-Nygell UA; Douglas KW; Jones DA; Lee SJ; Pulsipher M; Ritchie L; Halter J; Shaw BE;
    Bone Marrow Transplant; 2010 Aug; 45(8):1269-73. PubMed ID: 20023708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
    Blum W; Bolwell BJ; Phillips G; Farag SS; Lin TS; Avalos BR; Penza SL; Marcucci G; Byrd JC; Kalaycio ME; Sobecks RM; Pohlman B; Brown S; Elder PJ; Copelan EA
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):61-7. PubMed ID: 16399569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.
    Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socié G; ;
    Bone Marrow Transplant; 2006 Dec; 38(12):799-805. PubMed ID: 17075568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging of registered stem cell donors: implications for donor recruitment.
    Schmidt AH; Biesinger L; Baier D; Harf P; Rutt C
    Bone Marrow Transplant; 2008 Apr; 41(7):605-12. PubMed ID: 18071291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
    Elliott MA; Tefferi A; Hogan WJ; Letendre L; Gastineau DA; Ansell SM; Dispenzieri A; Gertz MA; Hayman SR; Inwards DJ; Lacy MQ; Micallef IN; Porrata LF; Litzow MR
    Bone Marrow Transplant; 2006 Jun; 37(11):1003-8. PubMed ID: 16604096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.